Document Detail


Prognostic value of surfactant proteins A and D in patients with acute lung injury.
MedLine Citation:
PMID:  12544988     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The primary objective of this study was to test the hypothesis that in patients intubated for acute lung injury, lower concentrations of surfactant proteins A and D in the pulmonary edema fluid and higher concentrations in the plasma are associated with more severe lung injury and worse clinical outcomes. DESIGN: Observational study. SETTING: Intensive care unit patients in a tertiary university hospital and a university-affiliated city hospital. PATIENTS: Thirty-eight intubated, mechanically ventilated intensive care unit patients with acute lung injury or acute respiratory distress syndrome as defined by the North American European Consensus Conference. INTERVENTIONS: Undiluted pulmonary edema fluid and plasma samples were collected within 24 hrs of endotracheal intubation in all patients. MEASUREMENTS AND MAIN RESULTS: The concentrations of surfactant proteins A and D were measured in pulmonary edema fluid and in plasma. Plasma surfactant protein A, but not surfactant protein D, was higher in patients with fewer days of unassisted ventilation (p = .03) and in patients with an absence of intact alveolar fluid clearance (p =.03). In contrast, pulmonary edema fluid surfactant protein D, but not surfactant protein A, was lower in patients with worse oxygenation, as measured by the alveolar-arterial oxygen difference (p = .01) and was lower in the patients who died (2646 ng/mL) compared with those who survived (5503 ng/mL; p = .02). CONCLUSIONS: These results demonstrate that reduced pulmonary edema fluid surfactant protein D and elevated plasma surfactant protein A concentrations at the onset of acute lung injury may be associated with more severe disease and worse clinical outcome and may serve as valuable biochemical markers of prognosis.
Authors:
Ivan W Cheng; Lorraine B Ware; Kelly E Greene; Thomas J Nuckton; Mark D Eisner; Michael A Matthay
Related Documents :
16210888 - Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonar...
3183748 - Detection and treatment of lung metastases of differentiated thyroid carcinoma in patie...
2927158 - Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates?
23173868 - Rumination variations: aetiology and classification of abnormal behavioural responses t...
15135458 - Anemia in the critically ill.
2068308 - Autourethrography.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Critical care medicine     Volume:  31     ISSN:  0090-3493     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2003-01-24     Completed Date:  2003-02-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  20-7     Citation Subset:  AIM; IM    
Affiliation:
Cardiovascular Research Institute and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Biological Markers
Female
Humans
Male
Prognosis
Pulmonary Edema / metabolism
Pulmonary Surfactant-Associated Protein A / blood,  metabolism*
Pulmonary Surfactant-Associated Protein D / blood,  metabolism*
Respiratory Distress Syndrome, Adult / diagnosis*,  metabolism
Statistics, Nonparametric
Grant Support
ID/Acronym/Agency:
HL03724/HL/NHLBI NIH HHS; HL51856/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Pulmonary Surfactant-Associated Protein A; 0/Pulmonary Surfactant-Associated Protein D
Comments/Corrections
Comment In:
Crit Care Med. 2003 Jan;31(1):311-3   [PMID:  12545037 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Drotrecogin alfa (activated) administration across clinically important subgroups of patients with s...
Next Document:  Risk factors for long intensive care unit stay after cardiopulmonary bypass in children.